Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2026-01-02 @ 9:01 AM
Study NCT ID:
NCT05009069
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-14
First Post:
2021-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-18
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-11-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-10
First Submit QC Date:
None
Study First Post Date:
2021-08-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-10-15
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-10-09
Last Update Post Date:
2025-10-14
Last Update Post Date Type:
ESTIMATED